Fidelity Advisor Biotechnology Fund - Class C (FBTCX)

Fund Assets	2.85B
Expense Ratio	1.76%
Min. Investment	$0.00
Turnover	n/a
Dividend (ttm)	1.44
Dividend Yield	7.63%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 26, 2024

Previous Close	19.38
YTD Return	-7.97%
1-Year Return	-16.06%
5-Year Return	9.60%
52-Week Low	n/a
52-Week High	n/a
Beta (5Y)	n/a
Holdings	96
Inception Date	Dec 27, 2000

About FBTCX

FBTCX was founded on 2000-12-27. The Fund's investment strategy focuses on Health/Biotech with 1.77% total expense ratio. The minimum amount to invest in Fidelity Advisor Series VII: Fidelity Advisor Biotechnology Fund; Class C Shares is $0 on a standard taxable account. Fidelity Advisor Series VII: Fidelity Advisor Biotechnology Fund; Class C Shares seeks capital appreciation by investing at least 80% of its assets in equity securities of firms engaged in research, development, distribution, and manufacture of various biotech products, services, and processes and firms benefiting from advances in biotechnology. Issuers may be foreign or domestic.

• Fund Family: Fidelity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: FBTCX
• Share Class: Class C
• Index: S&P 500 TR

Performance

FBTCX had a total return of -16.06% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.49%.

Chart

Bar chart with 6 bars.

The chart has 1 X axis displaying categories.

The chart has 1 Y axis displaying values. Data ranges from -16.060606060606062 to 7.483.

End of interactive chart.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
FIJYX	Class Z	0.61%
FBTIX	Class I	0.74%
FBTAX	Class A	1.01%
FBTTX	Class M	1.29%

Top 10 Holdings

66.48% of assets

Name	Symbol	Weight
AbbVie Inc.	ABBV	23.23%
Amgen Inc.	AMGN	7.83%
Gilead Sciences, Inc.	GILD	7.47%
Regeneron Pharmaceuticals, Inc.	REGN	7.34%
Alnylam Pharmaceuticals, Inc.	ALNY	6.12%
Ascendis Pharma A/S	ASND	4.87%
argenx SE	ARGX	4.17%
Nuvalent, Inc.	NUVL	2.08%
Xenon Pharmaceuticals Inc.	XENE	1.71%
Viridian Therapeutics, Inc.	VRDN	1.65%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 26, 2024	$1.441	Dec 27, 2024
Dec 17, 2021	$5.241	Dec 20, 2021
Jul 9, 2021	$0.006	Jul 12, 2021
Dec 18, 2020	$2.732	Dec 21, 2020
Dec 20, 2019	$1.849	Dec 23, 2019
Dec 7, 2018	$0.589	Dec 10, 2018